Our multidisciplinary research team structured itself in 2002, in the as a University Research team, then in 2004 as an INSERM labelled Team (ESPRI)” (Eri-9).

The team currently gathers 9 academic researcher (HDR), hematologists specialists of tissue factor (FT), Willebrand factor (VWF) and leucocytic activation, cardiologists specialists in atherosclerosis, angiogenesis, and endovascular treatment, cardiac surgeons specialists in valvulopathy, and cardiovascular radiologist.

(Translated by Google).

Heart, Vessels, Cell therapy, Atherosclerosis, Hemostasis, Tissue Factor, Von Willebrand Factor, Valve, Angiogenesis